Akt3 modulators
AssigneeGeorgiamune Inc.
InventorsSamir Khleif, Mikayel MKRTICHYAN, Malcolm MACCOSS
Life of this patent
Estimating the term…
Abstract
Compounds of Formula (I) are described, where the various substituents are defined herein. The compounds can modulate a property or effect of Akt3 in vitro or in vivo, and can also be used, individually or in combination with other agents, in the prevention or treatment of a variety of conditions. Methods for synthesizing the compounds are described. Pharmaceutical compositions and methods of using these compounds or compositions, individually or in combination with other agents or compositions, in the prevention or treatment of a variety of conditions are also described.
Claims89
A compound of Formula I:
- or a pharmaceutically acceptable salt thereof,
- wherein:
- is
- each occurrence of X1, X2, X3, X4, X5, X6, X7, X8, and X9 is independently CR1 or N;
- each occurrence of R1 is independently selected from the group consisting of H, D, halogen, (C1-C6)alkyl, (C1-C6)haloalkyl, (C2-C6)alkenyl, (C2-C6)haloalkenyl, (C2-C6)alkynyl, (C2-C6)haloalkynyl, (C3-C7)cycloalkyl, (C4-C10)bicycloalkyl, (C4-C14)tricycloalkyl, (C3-C7)heterocycloalkyl, halogenated (C3-C7)heterocycloalkyl, (C4-C10)heterobicycloalkyl, (C4-C14)heterotricycloalkyl, (C4-C10)heterospiroalkyl, (C3-C7)cycloalkenyl, (C3-C7)heterocycloalkenyl, (C4-C10)bicycloalkenyl, (C4-C10)heterobicycloalkenyl, (C4-C14)tricycloalkenyl, (C4-C14)heterotricycloalkenyl, aryl, heteroaryl, —ORa, —SRa, —N(Ra)2, —CORa, —CO2Ra, —CON(Ra)2, —CN, —NC, NO2, N3, —SO2Ra, —SO2N(Ra)2, —N(Ra)SO2Ra,
- and a partially saturated bicyclic heteroaryl optionally substituted by one or more (C1-C6)alkyl, halogenated (C1-C6)alkyl, —SO2Ra, or —SO2N(Ra)2;
- wherein the (C3-C7)cycloalkyl, (C4-C10)bicycloalkyl, (C4-C14)tricycloalkyl, (C3-C7)heterocycloalkyl, halogenated (C3-C7)heterocycloalkyl, (C4-C10)heterobicycloalkyl, (C4-C14)heterotricycloalkyl, (C4-C10)heterospiroalkyl, (C3-C7)cycloalkenyl, (C3-C7)heterocycloalkenyl, (C4-C10)bicycloalkenyl, (C4-C10)heterobicycloalkenyl, (C4-C14)tricycloalkenyl, (C4-C14)heterotricycloalkenyl, aryl, and heteroaryl of R1 are each optionally substituted by one or more (C1-C6)alkyl, halogenated (C1-C6)alkyl, halogen, —ORa, —CN, or —N(Ra)2;
- n is an integer from 0-4 where valence permits;
- Q is C(Ra)2, O, NRa, N(C═O)Ra, or NSO2Ra;
- Y1, Y2, Y3, Y4 and Y5 are each independently N or CR2 where valance permits;
- except that the moiety
- is connected to Y3 or Y5, and when connected to the moiety
- Y3 or Y5 is C;
- each occurrence of R2 is independently selected from the group consisting of H, D, halogen, (C1-C6)alkyl, (C1-C6)haloalkyl, (C2-C6)alkenyl, (C2-C6)haloalkenyl, (C2-C6)alkynyl, (C2-C6)haloalkynyl, (C3-C7)cycloalkyl, (C4-C10)bicycloalkyl, (C3-C7)heterocycloalkyl, (C4-C10)heterobicycloalkyl, (C4-C10)heterospiroalkyl, halogenated (C3-C7)heterocycloalkyl, aryl, heteroaryl, —ORa, —SRa, —N(Ra)2, —CORa, —CO2Ra, CON(Ra)2, —CN, —NC, NO2, N3, —SO2Ra, SO2N(Ra)2, —N(Ra)SO2Ra,
- each occurrence of R4 is independently selected from the group consisting of H, halogen, (C1-C6)alkyl, (C1-C6)haloalkyl, (C2-C6)alkenyl, (C2-C6)haloalkenyl, (C2-C6)alkynyl, (C2-C6)haloalkynyl, (C3-C7)cycloalkyl, (C3-C7)heterocycloalkyl, aryl, heteroaryl, —ORa, and —N(Ra)2;
- each occurrence of R5 is independently selected from the group consisting of H, halogen, (C1-C6)alkyl, (C1-C6)haloalkyl, (C2-C6)alkenyl, (C2-C6)haloalkenyl, (C2-C6)alkynyl, (C2-C6)haloalkynyl, (C3-C7)cycloalkyl, (C3-C7)heterocycloalkyl, aryl, heteroaryl, —ORa, and —N(Ra)2;
- or alternatively any two R4 groups connected to two adjacent carbons taken together with the two adjacent carbon atoms they are connected to form an optionally substituted (C3-C7)cycloalkyl, (C3-C7)heterocycloalkyl, or halogenated (C3-C7)heterocycloalkyl;
- m is an integer from 0-3;
- R6 is H, (C1-C6)alkyl, (C3-C7)cycloalkyl, (C3-C7)heterocycloalkyl, aryl, or heteroaryl;
- is
- Z is CR3 or N;
- W is O, NRs or S;
- wherein R8 is H, (C1-C6)alkyl, (C3-C7)cycloalkyl, (C3-C7)heterocycloalkyl, aryl, or heteroaryl;
- each occurrence of R3 is independently selected from the group consisting of H, halogen, (C1-C6)alkyl, (C1-C6)haloalkyl, (C2-C6)alkenyl, (C2-C6)haloalkenyl, (C2-C6)alkynyl, (C2-C6)haloalkynyl, —ORa, —N(Ra)2, —CORa, —CO2Ra, —CON(Ra)2, —CN, —NC, or —NO2;
- each occurrence of R7 is independently selected from the group consisting of H, halogen, (C1-C6)alkyl, (C1-C6)haloalkyl, (C2-C6)alkenyl, (C2-C6)haloalkenyl, (C2-C6)alkynyl, (C2-C6)haloalkynyl, —ORa, —SRa, —N(Ra)2, —CORa, —CO2Ra, —CON(Ra)2, —CN, —NC, —NO2, —N3, —SO2Ra, —SO2N(Ra)2, —N(Ra)SO2Ra,
- optionally substituted aryl, and optionally substituted heteroaryl;
- or alternatively any two R7 groups taken together with the carbon atom(s) they are connected to form a (C3-C7)cycloalkyl, (C3-C7)heterocycloalkyl, halogenated (C3-C7)heterocycloalkyl, aryl, or heteroaryl;
- p is an integer from 0-3 where valence permits;
- and
- each occurrence of Ra is independently H, (C1-C6)alkyl, (C2-C6)alkenyl, (C3-C7)cycloalkyl, aryl, or heteroaryl, or two Ra taken together form a 4-6-membered ring optionally substituted with halogen or (C1-C6)alkyl.
The compound of calim 9, wherein the structural moiety
- has the structure of
89-120. (canceled)
Dependencies are inferred from the claim text.